
Zhejiang Starry Pharmaceutical Co.,Ltd.
SSE:603520.SS
10.42 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||
Current Assets: | ||||||||||||||
Cash & Cash Equivalents
| 603.355 | 565.134 | 661.563 | 775.74 | 799.487 | 433.788 | 187.121 | 197.631 | 162.945 | 126.489 | 49.066 | 53.633 | 49.257 | 48.448 |
Short Term Investments
| 156.134 | 0.023 | 0.877 | 70.158 | 130.76 | -9.924 | -12.519 | -10.186 | -10.199 | -5.43 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 603.355 | 565.157 | 662.44 | 845.898 | 930.247 | 433.788 | 187.121 | 197.631 | 162.945 | 126.489 | 49.066 | 53.633 | 49.257 | 48.448 |
Net Receivables
| 441.422 | 497.258 | 711.184 | 676.561 | 429.557 | 342.484 | 327.324 | 239.266 | 137.362 | 170.465 | 102.544 | 147.334 | 90.704 | 0 |
Inventory
| 1,105.101 | 1,148.279 | 738.582 | 517.591 | 536.539 | 424.889 | 429.246 | 286.671 | 299.011 | 210.165 | 197.2 | 165.679 | 194.44 | 149.453 |
Other Current Assets
| 80.773 | 54.065 | 72.042 | 120.695 | 179.366 | 37.508 | 32.864 | 58.159 | 102.571 | 3.865 | 23.045 | 12.044 | 16.751 | 156.461 |
Total Current Assets
| 2,230.651 | 2,264.759 | 2,171.639 | 2,061.807 | 1,933.564 | 1,230.503 | 966.372 | 784.583 | 703.371 | 510.983 | 369.029 | 372.866 | 343.708 | 354.362 |
Non-Current Assets: | ||||||||||||||
Property, Plant & Equipment, Net
| 2,865.919 | 2,364.402 | 2,188.74 | 1,790.54 | 1,604.09 | 1,495.865 | 1,240.46 | 1,078.346 | 1,030.618 | 849.781 | 666.887 | 531.325 | 409.042 | 327.272 |
Goodwill
| 404.96 | 404.96 | 404.96 | 519.708 | 519.708 | 519.708 | 546.125 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 304.308 | 315.023 | 327.16 | 245.592 | 207.412 | 201.742 | 190.434 | 110.055 | 103.362 | 104.575 | 106.391 | 95.63 | 64.509 | 34.147 |
Goodwill and Intangible Assets
| 709.268 | 719.983 | 732.119 | 765.299 | 727.12 | 721.45 | 736.559 | 110.055 | 103.362 | 104.575 | 106.391 | 95.63 | 64.509 | 34.147 |
Long Term Investments
| 0 | 129.418 | 135.061 | 89.396 | -31.174 | 29.573 | 30.838 | 28.369 | 31.606 | 8.43 | 3 | 3 | 3 | 0 |
Tax Assets
| 36.957 | 21.717 | 22.497 | 14.392 | 5.475 | 4.797 | 6.813 | 4.201 | 4.141 | 3.209 | 1.297 | 0.53 | 0.524 | 0.847 |
Other Non-Current Assets
| 202.82 | 16.141 | 52.124 | 173.943 | 167.26 | 2.649 | 85.731 | 7.816 | 20.42 | 1.325 | 3.871 | 5.537 | 4.592 | 7.447 |
Total Non-Current Assets
| 3,814.964 | 3,251.661 | 3,130.542 | 2,833.571 | 2,472.772 | 2,254.335 | 2,100.401 | 1,228.788 | 1,190.147 | 967.321 | 781.446 | 636.022 | 481.667 | 369.713 |
Total Assets
| 6,045.615 | 5,516.42 | 5,302.18 | 4,895.378 | 4,406.335 | 3,484.838 | 3,066.773 | 2,013.371 | 1,893.519 | 1,478.304 | 1,150.475 | 1,008.888 | 825.376 | 724.075 |
Liabilities & Equity: | ||||||||||||||
Current Liabilities: | ||||||||||||||
Account Payables
| 532.862 | 508.099 | 540.635 | 590.944 | 295.932 | 294.962 | 114.649 | 62.519 | 71.57 | 87.435 | 91.639 | 68.692 | 71.139 | 79.198 |
Short Term Debt
| 1,440.594 | 1,855.028 | 2,106.641 | 893.233 | 665.631 | 1,238.726 | 983.211 | 534.668 | 538.3 | 519.902 | 342.378 | 328.021 | 244.571 | 207.5 |
Tax Payables
| 21.423 | 0.713 | 7.759 | 42.49 | 36.999 | 21.763 | 16.293 | 6.636 | 8.99 | 11.117 | 11.665 | 14.026 | 5.346 | 7.079 |
Deferred Revenue
| 0 | 0 | 10.439 | 133.242 | 139.758 | 58.903 | 16.293 | 33.723 | 36.269 | 36.776 | 33.319 | 29.75 | 17.995 | 30.754 |
Other Current Liabilities
| 682.487 | 567.551 | 104.755 | 86.295 | -35.483 | 37.691 | 146.89 | 28.293 | 29.973 | 26.162 | 21.895 | 74.916 | 91.903 | 23.777 |
Total Current Liabilities
| 2,677.366 | 2,931.391 | 2,759.79 | 1,886.06 | 1,525.732 | 1,593.142 | 1,261.044 | 632.117 | 648.833 | 644.616 | 467.577 | 485.655 | 412.959 | 317.555 |
Non-Current Liabilities: | ||||||||||||||
Long Term Debt
| 537.285 | 734.464 | 675.391 | 746.554 | 994.509 | 841.663 | 864.594 | 490.3 | 387.4 | 354.281 | 226.647 | 110 | 49 | 85.224 |
Deferred Revenue Non-Current
| 101.948 | 0 | 94.41 | 43.348 | 22.942 | 21.325 | 18.171 | 18.514 | 30.271 | 21.708 | 24.119 | 27.127 | 26.61 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 1.375 | 1.02 | 992.947 | -841.663 | -864.594 | -490.3 | -387.4 | -354.281 | -226.647 | -27.127 | -26.61 | 0 |
Other Non-Current Liabilities
| 94.569 | 91.665 | 0 | 47.206 | 22.942 | 21.325 | 18.171 | 0 | 30.271 | 0 | 0 | 0 | 0 | 19.49 |
Total Non-Current Liabilities
| 733.802 | 826.129 | 771.176 | 794.78 | 1,015.888 | 862.989 | 882.766 | 508.814 | 417.671 | 375.989 | 250.765 | 137.127 | 75.61 | 104.714 |
Total Liabilities
| 3,411.168 | 3,757.52 | 3,530.966 | 2,680.84 | 2,541.62 | 2,456.131 | 2,143.81 | 1,140.931 | 1,066.504 | 1,020.605 | 718.343 | 622.782 | 488.57 | 422.268 |
Equity: | ||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 438.41 | 342.515 | 342.914 | 245.017 | 244.905 | 167.898 | 120 | 120 | 120 | 90 | 90 | 90 | 90 | 90 |
Retained Earnings
| 387.101 | 458.121 | 483.953 | 689.52 | 526.776 | 365.47 | 246.107 | 227.036 | 193.009 | 163.849 | 151.441 | 118.202 | 74.871 | 42.994 |
Accumulated Other Comprehensive Income/Loss
| 0 | -0.876 | 161.486 | 144.297 | 105.655 | 82.262 | 68.955 | 54.169 | 41.079 | 30.118 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 1,802.645 | 952.845 | 938.373 | 1,096.144 | 1,054.166 | 380.167 | 525.051 | 455.978 | 455.978 | 156.567 | 179.649 | 172.183 | 165.356 | 161.449 |
Total Shareholders Equity
| 2,628.156 | 1,752.605 | 1,765.24 | 2,174.978 | 1,823.503 | 995.797 | 891.04 | 857.183 | 810.066 | 440.534 | 421.089 | 380.385 | 330.227 | 294.443 |
Total Equity
| 2,634.447 | 1,758.9 | 1,771.214 | 2,214.538 | 1,864.715 | 1,028.707 | 922.964 | 872.44 | 827.015 | 457.698 | 432.132 | 386.106 | 336.806 | 301.807 |
Total Liabilities & Shareholders Equity
| 6,045.615 | 5,516.42 | 5,302.18 | 4,895.378 | 4,406.335 | 3,484.838 | 3,066.773 | 2,013.371 | 1,893.519 | 1,478.304 | 1,150.475 | 1,008.888 | 825.376 | 724.075 |